Inovalon Acquires VigiLanz

Nordic Capital-Led Consortium Takes Inovalon Private

November 24, 2021

Healthcare Services

Inovalon, a cloud-based healthcare data platform provider, was acquired in an all-cash transaction by an equity consortium led by Nordic Capital and joined by Insight Partners, 22C Capital, and Inovalon founder and CEO Keith Dunleavy, M.D., along with certain Class B stockholders. The deal values Inovalon at an enterprise value of about $7.3 billion and provides Inovalon stockholders $41.00 per share in cash to take the company private.

Voiant Acquires Voxeleron

August 2, 2025

AI & Machine Learning

Voiant has acquired Voxeleron, an AI-driven ophthalmic image analysis company, to integrate advanced AI/ML imaging capabilities into its clinical trial imaging platform. The deal combines Voiant’s clinical trial imaging expertise with Voxeleron’s cloud-based image analysis tools to accelerate biomarker development, improve data accuracy, and enhance ophthalmology-focused clinical research services.

Eli Lilly Acquires Versanis Bio

July 14, 2023

Biotechnology

Eli Lilly has entered into a definitive agreement to acquire Versanis Bio, a private clinical-stage biopharmaceutical company developing bimagrumab for cardiometabolic diseases and obesity. The deal could deliver up to $1.925 billion to Versanis shareholders and is intended to combine Versanis’ activin/myostatin biology expertise with Lilly’s incretin portfolio to advance combination treatments for obesity and related cardiometabolic conditions.

Reveleer Acquires Novillus

April 22, 2025

Healthcare Services

Reveleer, a value-based care technology platform, has acquired Novillus, a provider of care gap management and provider engagement solutions, to expand its AI-powered clinical intelligence and quality-improvement capabilities. The acquisition strengthens Reveleer's ability to support payers and providers in closing care gaps, improving regulatory compliance, and enhancing Medicare Advantage Star performance across its customer base.

ELIQUENT Life Sciences Acquires Truliant Consulting

April 2, 2025

Healthcare Services

ELIQUENT Life Sciences has acquired Truliant Consulting, a Baltimore-based pharmacovigilance, risk management, and regulatory compliance advisory firm. The acquisition expands ELIQUENT's pharmacovigilance platform and capabilities to provide broader, technology-driven, and scalable safety and regulatory solutions to life sciences clients.

VitalHub Acquires Novari Health

July 7, 2025

Healthcare Services

VitalHub Corp. has acquired Novari Health Inc., a Kingston-based provider of patient flow and referral management software, for total up-front consideration of $43.6 million plus potential performance-based consideration (up to $5.0 million earnout). The acquisition strengthens VitalHub's patient-flow and referral management capabilities and is expected to accelerate Novari's international expansion leveraging VitalHub's footprint, particularly in the UK.